Articles tagged with Pharmaceutical Industry
Insilico Medicine has secured a $110 million Series E financing to accelerate the advancement of its AI-driven drug discovery pipeline and platform developments. The funds will focus on refining AI models and algorithms, as well as advancing clinical validation of its flagship candidate for idiopathic pulmonary fibrosis treatment.
CrySyst's QbC framework addresses crystallization monitoring, modeling and control using research from Purdue University. The software provides guided experiment selection, semiautomated model development and reliable solutions to reduce time and material usage.
Hunter Medical Research Institute has formed a memorandum of understanding with Novartis (Aust & NZ) to explore future research projects focused on improving cardiovascular health. The partnership aims to accelerate innovation and enhance patient care through collaborative research initiatives.
Biomedical engineers at Duke University have developed a new technique that traps together cellular machinery to increase protein production rates. This approach uses synthetic disordered proteins to form compartments called biological condensates, which enhance the rate of protein production by bringing together biomolecular machinery...
The Young Institute Pharmaceutical Manufacturing Consortium aims to pioneer advances in pharmaceutical manufacturing with a focus on sterile injectables and innovative aseptic manufacturing technology. The collaboration will develop disruptive technologies, autonomous systems, and smart AI and digital technology.
Biofilm produced by Pseudomonas alcaligenes has unique structural properties and thermal stability, exhibiting antioxidant, emulsification and flocculation activity. The EPS can be used as a natural additive for the pharmaceutical and food industries with potential applications in developing sustainable or ecofriendly additives.
Researchers used drum mills to manufacture kilograms of ibuprofen-nicotinamide, a formulation that improves therapeutic efficacy and stability. The study demonstrates the possibilities of drum mills for large-scale synthesis of pharmaceutical co-crystals.
A new analysis reveals critical gaps in the UK's self-regulated system for disclosing payments from drug companies to healthcare professionals and organisations. The study finds billions of pounds in untraceable research payments and non-research payments lack clarity, with significant breaches by major companies. Researchers are calli...
A new study highlights the risk of patient organizations losing independence due to funding from pharmaceutical companies. Researchers propose establishing a single database to track payments made to patient groups, doctors, and hospitals to improve transparency.
Researchers from Institute of Science Tokyo successfully developed a multi-element perovskite catalyst that selectively oxidizes light alkanes to alcohols with high yield and selectivity. The breakthrough catalyst operates under mild conditions and exhibits excellent stability and reusability.
Researchers developed a platform to produce mature, uniform organoids using a three-dimensional engineered membrane. This breakthrough enables consistent quality and improved efficiency for practical applications in clinical trials and drug development.
A study found that 64% of clinical trials for the top 30 highest-revenue medicines had their data accessible to researchers, a significant improvement over prior assessments. Companies using independent platforms achieved higher eligibility rates than those relying on internal processes.
A recent Stanford University study has identified 33 current faculty members from Binghamton University as among the top 2% of all researchers worldwide in their fields. The researchers were ranked based on their career-long or single-year output and citation metrics, indicating their significant impact on their respective fields.
The university introduces Bachelor of Engineering in Robotics and Double Major Bachelor of Engineering Science in Process Engineering and Synthetic Chemistry to address global demand for roboticists. The programs incorporate AI-related elements and are designed to provide students with a unique skill set.
Researchers propose utilizing human 3D skin models to assess drug binding properties across different skin types. Genetic variations among minority groups can lead to starkly different drug responses across races and ethnicities.
Researchers from Tokyo University of Science have developed a new type of micelle that can effectively dissolve dyes, paving the way for more efficient and cost-effective formulations. The micelles were created using block copolymers and showed improved dye solubilization capacity compared to random copolymers.
Recent research highlights microwave-induced synthesis as a transformative potential in drug discovery and development. This efficient technique enables rapid preparation of diverse N-heterocycles, including biologically active molecules such as pyrimidines, thiazoles, and quinolines.
A recent study reveals that pharmaceutical industry sponsors dominate US cancer research, with a substantial increase in industry-sponsored clinical trials over the past decade. Federally funded studies have been underinvested and have missed opportunities for scientific advancements.
The European capacity for antibiotic research and development requires sustained investment to combat growing resistance. Collaboration and risk-sharing can help keep companies in anti-infective drug development, as a temporary funding strategy may lead to lost efforts.
Researchers at KIT develop new NMR spectroscopy method to directly measure chiral molecular structure. This enables accelerated drug screening and simplifies the search for active ingredients in pharmaceuticals. The breakthrough could lead to significant improvements in drug development.
A team of chemists has developed a novel tool to streamline the drug-making process, enabling researchers to create new molecules quickly and efficiently. The discovery of stable nickel complexes can help reduce the time to market for life-saving medicines while increasing drug efficacy and reducing side effects.
Researchers at the California Institute of Technology have successfully developed a method to recycle samarium diiodide, a crucial reagent in synthesizing molecules that can lead to new pharmaceuticals. This breakthrough enables large-scale industrial production, making it possible to create essential compounds like taxol, an anticance...
Researchers developed a one-pot process to transform aromatic ketones into esters, simplifying the reaction process, reducing reaction times, and minimizing purification steps. The method enables seven different chemical transformations and has shown notable stability and reusability, making it scalable for industrial applications.
Five pioneering firms in agriculture, manufacturing, and pharma retail have demonstrated businesses can catalyze social and environmental change. They address complex issues using scientific methods, partner with NGOs, and prioritize purpose alignment.
Research from Bentley University shows that biotechnology companies can maintain current levels of new drug approvals in face of global revenue reductions. Strategic distribution of cost reductions and continued investment in early-stage development by biotech firms sustain pipeline, contradicting industry claims.
A Tulane University study found that pharmacists have the best success rates in helping patients with high blood pressure get their hypertension under control. Pharmacists achieved the greatest improvements, followed by community health workers, who also saw significant reductions in blood pressure.
Researchers at NUS have developed a novel method for creating 1,2-arylheteroaryl ethanes using fundamental feedstock chemicals. The new approach enables the modular assembly of diverse molecular scaffolds with potential applications in pharmaceuticals and petrochemical industries.
Researchers isolated three bacterial strains that produce amylase enzymes from sugar factory waste, showing great potential for production. The optimal conditions for amylase production were found to be 37°C and pH 7.0, leading to increased enzyme activity.
A new study by the University of Toronto Nursing found that over one million industry-sponsored events took place in the US in 2022, with a focus on physician and nurse practitioner interactions. These events were linked to specific pharmaceutical products, indicating their potential impact on prescribing practices.
Researchers at Tokyo University of Science have developed a new method to synthesize complex sulfur molecules, including phenothiazines and thianthrenes, with high stability and control over reaction conditions. This approach uses readily available aryne precursors and avoids foul odors associated with conventional methods.
Researchers at Colorado State University have developed a new approach to speed up the development of pharmaceuticals and pesticides. By deconstructing and reassembling common compounds known as heterocycles, scientists can rapidly change their characteristics without extensive synthesis.
LyoWave is commercializing microwave heating technologies developed at Purdue University, improving speed, cost-effectiveness, and product throughput. The company has entered a collaboration with Millrock Technology, applying its technology to boost freeze-drying systems' capacity for pharmaceuticals and diagnostic reagents.
Scientists have found an effective treatment for spitting cobra snakebites by blocking one of the major dermonecrosis-causing toxins with varespladib. The study suggests that this repurposed drug can prevent tissue damage and may become a valuable treatment against black-necked and red spitting cobra venoms.
A study published in JAMA analyzed industry payments to US physicians, finding that over half received at least one payment and 94% were associated with marketed medical products. Orthopedic surgeons received the most payments, while pediatric surgeons received the fewest.
Researchers at Xi'an Jiaotong-Liverpool University developed a new method that enables the efficient production of cysteine-rich peptides and microproteins in their naturally folded 3D structure. The approach uses organic solvents to mimic nature's oxidative folding process, resulting in speeds of over 100,000 times faster than aqueous...
Researchers developed an AI-driven lab called Fast-Cat that uses artificial intelligence to provide in-depth analyses of catalytic reactions. The tool conducts high-temperature gas-liquid reactions and analyzes results to determine how different variables affect the outcome of each experiment.
A UCF-developed technology uses a plasmonic platform to detect the chirality of molecules with high precision, enabling more accurate drug development and therapies. The platform improves upon current methods with sensitivity nearly 13 orders of magnitude greater.
A new study reveals that utilization of PCSK9 inhibitors is low among high-risk patients, despite extensive evidence documenting their role in LDL-C reduction and the prevention of heart attacks. The study found that insurance coverage rejection or abandonment leads to significantly more cardiovascular events within 12 months.
Researchers at Salk Institute find a new method to interrupt sperm production using an HDAC inhibitor, which blocks fertility without affecting libido. The treatment's reversibility is attributed to its ability to modulate gene expression downstream of retinoic acid.
Processing times for complaints against UK drug companies have tripled over nearly two decades, from less than three months to over eight and a half months. The industry's trade body has raised fees related to these complaints by more than 40% in an effort to tackle the backlog.
A new study suggests Mexico can grow its economy by building biorefineries to produce biofuels, chemicals, and pharmaceuticals from abundant organic waste materials. The research promotes the adoption of sustainable practices to achieve UN Sustainable Development Goals 8-12.
Scientists at the University of Rochester discovered that even small differences in grain shape can significantly alter grain segregation in dry and wet conditions. The study highlights the importance of interdisciplinary research to better understand and predict geohazards and alleviate segregation issues in industrial flows.
Despite a lack of clinical efficacy evidence, phenylephrine remained the most common oral decongestant in the US from 2012-2021, with hundreds of millions of units sold annually. Most phenylephrine products were co-formulated with antihistamines or antitussives, providing symptom relief for cough and cold symptoms.
A new study found that phenylephrine is the most popular nasal decongestant despite lack of evidence supporting its effectiveness. Removal from the market could disrupt supply chains and require significant investment in infrastructure for over-the-counter drug review.
Researchers at Delft University of Technology have developed pioneering advancements in the purification of isopropanol and acetone from waste gases through engineered bacteria. The novel process shows high-purity yields with recoveries over 99.2%, marking a significant step forward in sustainable industrial fermentation.
A study published by Geisinger College faculty and graduate students found that 55% of DSM-5-TR panel members received payments from industry, highlighting the need for stricter standards. The researchers argue that individuals with financial ties to industry should not have decision-making authority in guideline development.
Scientists in Germany developed a new analytical method to precisely elucidate the size of particles, structure, and RNA molecules in pharmaceutical products. This information can help evaluate product quality, enabling improved development of new products.
Researchers at the University of Bath have created a novel bacterial system to mass-produce cyclic proteins and peptides, addressing a significant bottleneck in the development of new therapeutic treatments. By harnessing the natural cyclization process from the Oldenlandia flower, they improved heat and chemical stability, as well as ...
A study published in the Canadian Medical Association Journal found that about 1 in 10 prescription drugs has a manufacturer-sponsored patient support program. These programs offer financial, nursing, and educational supports to patients, primarily for expensive and rare disease drugs.
Researchers at CABBI developed an economical method for producing succinic acid, a key chemical in food, agricultural, and pharmaceutical products, using acid-tolerant yeast. The new pipeline eliminates costly downstream processing steps, significantly reducing costs and emissions.
A University at Buffalo-led research team has created a new, sturdier membrane that can withstand harsh environments associated with industrial separation processes. The membrane, made from an inorganic material called carbon-doped metal oxide, is a potential alternative to energy-intensive processes like distillation and crystallization.
A new study calls for stronger regulation of pharmaceutical industry marketing practices to enhance patient health and safety. Healthcare professionals and organisations need to distance themselves from offending companies and demand tougher action.
Research has clarified how starch granules form in wheat seeds, unlocking diverse potential benefits for various industries. The discovery of the enzyme PHS1 crucial for B-type granule initiation offers opportunities to create variations in starch for different food and industrial applications.
A new fund to fast-track patient access to potentially valuable new medicines may incentivise the pharmaceutical industry to develop high-priced drugs for rare diseases with weak clinical evidence. The NHS England Innovative Medicines Fund risks disincentivising the generation of essential evidence if not implemented appropriately.
A Texas A&M University team is exploring 3D printing to create tailored medication dosage and tablet size for young children, addressing the need for greater flexibility in administering medications. The project aims to maintain drugs' integrity and effectiveness while advancing the field of pharmaceutical manufacturing.
Researchers from Tokyo University of Science have developed an innovative method to synthesize azide compounds with a protected azido group, facilitating the efficient synthesis of organonitrogen compounds. This novel approach enables the creation of a wide range of azides through transformations with various electrophiles.
Researchers found that translating consent documents can discourage investigators from recruiting patients with limited English proficiency, contributing to low rates of participation from underrepresented groups. By relieving investigators of these costs, studies can become more inclusive and results more accurate and generalizable.
A new method for polyurethane synthesis without isocyanates was developed by Kobe University and AGC Inc. using fluorinated compounds, enabling the creation of highly elastic, wear-resistant, and durable polyurethanes with improved environmental sustainability.
A new study by Bentley University reveals the NIH's significant investment in pharmaceutical innovation, with $8.1 billion spent on phased clinical trials between 2010-19. The funding represents only ~10% of reported industry costs for these trials, highlighting the public sector's limited contribution to drug development.
Researchers have developed a method to produce pharmaceutical precursors from biorenewable β-pinene, a waste by-product from the paper industry. They successfully created paracetamol and ibuprofen using this compound, presenting a potential alternative to crude oil-based products.